The main downstream effectors of PI3K are AKT and mTOR (mammalian targets of rapamycin), and the pathway bears a fundamental oncogenic role in driving tumor evolution and progression in pancreatic cancer. This evidence concerns the gene MTOR and familial pancreatic carcinoma.